Portfolio (Quarterly)
Guide ↗
Medicxi Ventures Management (Jersey) Ltd
· CIK 0001715579| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 19,963,157.0 | $499.3M | 59.80% | — | — | $25.01 | +58.6% |
| 2 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 7,464,572.0 | $123.8M | 14.83% | — | — | $16.59 | -29.2% |
| 3 | — | NEWAMSTERDAM PHARMA COMPANY | — | 2,869,565.0 | $100.7M | 12.06% | — | — | $35.08 | — |
| 4 | — | RAPT THERAPEUTICS INC | — | 2,794,000.0 | $94.6M | 11.33% | — | — | $33.87 | — |
| 5 | AURA | AURA BIOSCIENCES INC | Healthcare | 3,039,892.0 | $16.6M | 1.98% | — | — | $5.45 | +36.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%